postheadericon Receptor Tyrosine Kinases (RTKs)

Human genome encodes 58 receptor type protein tyrosine kinases (RTKs) and 32 non-receptor type protein tyrosine kinases (Robinson et al., 2000) (Fig. 1). Each RTK contains a glycosylated extracellular ligand-binding domain with different sequence motifs, a single transmembrane portion and an intracellular domain with Tyr kinase activity that catalyzes the transfer of the γ-phosphate of bound ATP to the C-terminal domains and the Tyr residues of exogenous substrates (Blume-Jensen & Hunter, 2001). 48 human proteins have a kinase-like domain that lacks at least one of the conserved catalytic residues; these proteins are therefore predicted to be inactive and have been termed pseudokinases (Boudeau et al., 2006). RTKs are structurally diverse: 20 subfamilies/classes have been described so far (Lemmon and Schlessinger, 2010), and the members of a subfamily often bind common or similar ligands:

1) ErbB or Epidermal growth factor receptor subfamily

  • ErbB1 (EGFR)
  • ErbB2 (HER2, Neu)
  • ErbB3 (HER3)
  • ErbB4 (HER4, Tyro2)

  • 2) INSR - Insulin receptor subfamily
  • IR (InsR)
  • IGF1R
  • IRR (InsRR)
  • 3) PDGFR - Platelet-derived growth factor subfamily
  • PDGFRa
  • PDGFRb
  • CSF1R (Fms)
  • Kit (SCFR)
  • Flt3 (Flk2, Stk1)
  • 3) FGFR - Fibroblast growth factor receptor subfamily
  • FGFR1 (Flg)
  • FGFR2 (KGFR, Bek)
  • FGFR3
  • FGFR4
  • 4) VEGFR - Vascular endothelial growth factor receptor subfamily
  • VEGFR1 (Flt1)
  • VEGFR2 (Flk1, KDR1)
  • VEGFR3 (Flt4)
  • 5) HGFR - Hepatocyte growth factor receptor subfamily
  • c-Met (HGFR, HGF/SFR)
  • Ron (MSPR)
  • 6) TRK - neurotrophic factor receptor subfamily
  • TrkA (NFGR)
  • TrkB (BDNFR)
  • TrkC (NT3 receptor)
  • 7) EPH - Ephrin receptor subfamily
  • EphA1 (Eph, Esk)
  • EphA2 (Eck)
  • EphA3 (Mek4, Hek, Tyro4)
  • EphA4 (Sek, Sek1, Hek8, Tyro1)
  • EphA5 (Ehk1, Bsk, Hek7, Rek7)
  • EphA6 (Ehk2)
  • EphA7 (Mdk1, Hek11, Ehk3, Ebk)
  • EphA8 (Eek)
  • EphA10
  • EphB1 (Elk, Net)
  • EphB2 (Nuk, Erk, Sek3, Hek5, Drt)
  • EphB3 (Hek2, Mdk5, Sek4)
  • EphB4 (Htk, Myk1, Mdk2, Hek5)
  • EphB6 (Mep)
  • 8) PTK7 - pseudo protein tyrosine kinase 7/colon carcinoma kinase-4 receptor subfamily
  • PTK7 (CCK4, Klg)
  • 9) TAM/AXL
  • Axl (Ufo, Ark, Tyro7)
  • Mer (Eyk, Nyk)
  • Rse (Tyro3, Brt, Sky, Tif, Dtk, Etk2)
  • 10) ROR - Retinoid-related orphan receptor subfamily
  • Ror1 (NTRKR1)
  • Ror2 (NTRKR2)
  • 11) MuSK - Muscle-specific kinase receptor subfamily
  • MuSK (Nsk)
  • 12) TIE - angiopoietin receptor subfamily
  • Tie1
  • Tie2 (Tek)
  • 13) RET - glial cell line-derived neurotrophic factor (GDNF) receptor subfamily
  • Ret
  • 14) RYK - receptor related to tyrosine kinases (Derailed receptor) subfamily
  • Ryk
  • 15) DDR - Discoidin domain receptor subfamily
  • DDR1 (Nep, Cak, TrkE, Ntrk4)
  • DDR2 (Tkt, Tyro10)
  • 16) ROS - c-ros oncogene 1 receptor subfamily
  • Ros
  • 17) LMR - lemur kinase receptor subfamily
  • LMR1
  • LMR2
  • LMR3
  • 18) ALK - Anaplastic Lymphoma Kinase receptor subfamily
  • ALK
  • LTK (Leukocyte tyrosine kinase)
  • 19) STYK1 - serine/threonine/tyrosine kinase 1 receptor subfamily
  • SuRTK106/STYK1
  • 20) AATYK - Apoptosis Associated Tyrosine Kinase receptor subfamily
  • AATYK
  • AATYK2
  • AATYK3
  • NOTE
    If your institution can not access the publication that you really really need, you may email me with the title Article Request. Be polite, and I will see if I can get the pdf and send it to you.
    Free Reviews
    Various

    The role of angiogenic growth factors in organogenesis

    ErbB

    The ErbB signaling network

    EGFR

    Untangling The ErbB Signalling Network

    The oncogene HER2

    ErbB receptors

    ErbB receptors and cancer

    ErbB signaling towards systems level

    InsR and IGF-1R

    The Insulin Receptor and Its Cellular Targets

    Modulation of insulin action

    Insulin-like growth factors

    The IGF system

    VEGFR

    2014 - Angiogenesis and VEGF in Wound Repair

    2011 - VEGF and its receptor signaling in angiogenesis

    2007 - VEGF Signaling in Tumor Progression

    2006 - VEGFR signalling

    2000 - VEGFR Signaling in Tumor Angiogenesis

    PDGFR

    Regulation of PDGF and its receptors in fibrotic diseases

    PDGFR as Targets

    c-Met

    Targeting MET in cancer

    MET signalling

    HGF twenty years on

    Ron in Tumor Growth & Metastasis

    MET in Invasion and Metastasis

    Potential therapeutics specific to c-MET/RON

    FGFR

    FGF in stem cell self-renewal, senescence and aging

    FGF receptors in cancer

    Roles of FGFR in carcinogenesis

    De-regulated FGFR as therapeutic targets in cancer

    TRK

    Neurotrophin-regulated signalling pathways

    Neurotrophins in Neoplasias

    Eph

    Ephrin molecules - a hub for signaling and endocytosis

    Ephrins and EphR in stem cells and cancer

    EphR and ephrins in cancer

    ROS

    ROS receptor tyrosine kinase

    PTK7

    The many roles of PTK7

    TAM/AXL

    Axl-dependent signalling

    TAM Receptor Tyrosine Kinases

    ROR

    ROR receptors

    TIE

    Angiopoietin: a TIE(d) balance in tumor angiogenesis

    Signaling and Functions of Ang-1 in Vascular Protection

    Angiopoietins: a link between angiogenesis and inflammation

    RET

    Targeting RET activation in cancer

    RET-related genetics, signaling and therapeutics

    RYK

    Revelations of the RYK receptor

    RET-related genetics, signaling and therapeutics

    DDR

    Discoidin domain receptors

    DDR new players in cancer progression

    An update on DDR function

    ALK

    ALK signalling in development and disease

    Pathogenic and therapeutic importance of ALK gene

    Diverse ALK roles

    MuSK

    The synaptic MuSK complex

    MuSK: organiser of synaptic membrane domains